Open Access Open Access  Restricted Access Subscription Access

Flavonoids as Modulators of Gut Integrity and Inflammation in Inflammatory Bowel Disease

Shivanshu Sharma, Dil Prasad Subba

Abstract


Inflammatory Bowel Disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a long-lasting inflammatory disorder of the digestive system. The precise cause of IBD is still unknown, but it includes a complex interaction of genetic, environmental, and immune factors. While conventional treatments primarily focus on managing inflammation and symptoms, their long-term use often leads to significant side effects, prompting a search for alternative therapies. Flavonoids, a diverse group of polyphenolic compounds found in fruits, vegetables, and other plant-based foods, have emerged as potential therapeutic agents due to their anti-inflammatory, antioxidant, and immunomodulatory properties. This chapter explores the role of flavonoids in the management of IBD, detailing their mechanisms of action, including the inhibition of key inflammatory signaling pathways, reduction of oxidative stress, modulation of gut microbiota, and regulation of immune responses. Preclinical studies demonstrate the efficacy of various flavonoids in animal models of IBD, while clinical trials present mixed but promising results. Practical considerations for dietary incorporation and supplementation of flavonoids are discussed, along with future research directions aimed at optimizing their therapeutic potential. Integrating flavonoid-rich foods into a balanced diet may offer a natural and holistic approach to support the management of IBD, highlighting the need for further research to establish comprehensive guidelines for their use in clinical practice.


Full Text:

PDF

References


Dmochowska N, Wardill HR, Hughes PA. Advances in Imaging Specific Mediators of Inflammatory Bowel Disease.Int J Mol Sci. 2018 Aug 21;19(9) [PMC free article] [PubMed]

Colombel JF, Shin A, Gibson PR. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. ClinGastroenterolHepatol.2019 Feb;17(3):380-390.e1. [PMC free article] [PubMed]

D’Inca, R., Cardin, R., Benazzato, L., Angriman, I., &Martines, D. (2011). "Chronic inflammation in inflammatory bowel disease: Clinical and molecular aspects." Pathobiology, 78(1), 1-10. doi:10.1159/000322769.

Farzaei, M. H., Abdollahi, M., &Rahimi, R. (2015). "Role of dietary polyphenols in the management of peptic ulcer." World Journal of Gastroenterology, 21(21), 6499-6517. doi:10.3748/wjg.v21.i21.6499.

Hart, A. L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., &Campieri, M. (2004). "Modulation of human dendritic cell phenotype and function by probiotic bacteria." Gut, 53(11), 1602-1609. doi:10.1136/gut.2003.037325.

Kim, Y. S., & Milner, J. A. (2007). "Dietary modulation of colon cancer risk."Journal of Nutrition, 137(11), 2576S-2579S. doi:10.1093/jn/137.11.2576S.

Liu, R. H. (2013). "Dietary bioactive compounds and their health implications."Journal of Food Science, 78(s1), A18-A25. doi:10.1111/1750-3841.12031.

Mazzon, E., &Cuzzocrea, S. (2006). "Role of TNF-alpha in the pathogenesis of inflammatory bowel disease: Gene therapy and the development of novel anti-TNF-alpha drugs." Mini Reviews in Medicinal Chemistry, 6(10), 1335-1342. doi:10.2174/138955706778225452.

Min, Y. D., Choi, C. H., Bark, H., Sohn, E. H., & Lee, S. R. (2007). "Inhibition of the NF-κB signaling pathway by the peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ12,14-prostaglandin J2 in human mast cells." Journal of Pharmacology and Experimental Therapeutics, 322(1), 368-374. doi:10.1124/jpet.107.120584.

Nair, S. V., Gupta, P., &Kakkar, V. (2018). "An insight into the potential of flavonoids as anticancer agents." Biomedicine & Pharmacotherapy, 100, 131-145. doi:10.1016/j.biopha.2018.01.138.


Refbacks

  • There are currently no refbacks.